Key Events This Week
16 Mar: Stock hits 52-week low at Rs.101.15 amid sector pressures
20 Mar: Valuation shifts to fair grade as price rises to Rs.119.65
Mar 30
BSE+NSE Vol: 1.78 k
16 Mar: Stock hits 52-week low at Rs.101.15 amid sector pressures
20 Mar: Valuation shifts to fair grade as price rises to Rs.119.65

Vasundhara Rasayans Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Dec 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 20 March 2026, providing investors with the latest insights into the stock’s performance and outlook.
Read full news article
Vasundhara Rasayans Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. This change reflects evolving market perceptions amid a challenging price performance and a competitive peer landscape. Investors are advised to carefully analyse the company’s current price-to-earnings (P/E) and price-to-book value (P/BV) ratios in relation to historical averages and sector benchmarks to assess its price attractiveness.
Read full news article
Vasundhara Rasayans Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, touched a new 52-week low of Rs.101.15 today, marking a significant decline amid a volatile trading session. The stock’s performance continues to lag behind broader market indices and sector peers, reflecting ongoing pressures on its financial metrics and market positioning.
Read full news article
09 Mar: Stock hits 52-week low at Rs.106
10 Mar: Valuation metrics shift to attractive territory
13 Mar: Week closes at Rs.112.10 (-6.58%)

Vasundhara Rasayans Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from fair to attractive territory. Despite a challenging market environment and significant share price declines, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a compelling case for value investors seeking opportunities in the sector.
Read full news article
Vasundhara Rasayans Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.106 today, marking a significant downturn in its stock performance amid broader market weakness and company-specific pressures.
Read full news article
Vasundhara Rasayans Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 March 2026, providing investors with the latest insights into its performance and outlook.
Read full news articleNewspaper Advertisement pertaining to un-audited financial results of the Company for the quarter ended on December 31 2025
Board approved the Un-audited Financial Results of the Company for the quarter ended on 31st December 2025 and Limited Review Report
Approved Financial Results and Limited Review Report for the Quarter ended on 31.12.2025
No Upcoming Board Meetings
Vasundhara Rasayans Ltd has declared 20% dividend, ex-date: 19 Sep 25
No Splits history available
No Bonus history available
No Rights history available